David Windley
Stock Analyst at Jefferies
(4.58)
# 234
Out of 5,241 analysts
209
Total ratings
68.03%
Success rate
14.66%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $340 → $373 | $393.85 | -5.29% | 29 | Apr 20, 2026 | |
| ELV Elevance Health | Maintains: Buy | $395 → $391 | $392.68 | -0.43% | 2 | Apr 20, 2026 | |
| CI The Cigna Group | Maintains: Buy | $333 → $330 | $285.27 | +15.68% | 18 | Apr 20, 2026 | |
| CNC Centene | Maintains: Hold | $37 → $39 | $58.27 | -33.07% | 29 | Apr 20, 2026 | |
| OSCR Oscar Health | Upgrades: Hold | $10 → $16 | $23.32 | -31.39% | 2 | Apr 20, 2026 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $175 → $135 | $116.38 | +16.00% | 16 | Feb 23, 2026 | |
| MEDP Medpace Holdings | Upgrades: Buy | $560 | $415.27 | +34.85% | 7 | Feb 13, 2026 | |
| HUM Humana | Maintains: Buy | $310 → $235 | $305.12 | -22.98% | 20 | Feb 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $255 | $169.12 | +50.78% | 6 | Feb 6, 2026 | |
| DEO Diageo | Downgrades: Neutral | n/a | $81.69 | - | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $9.5 | $13.66 | -30.45% | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $142 → $195 | $150.85 | +29.27% | 20 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $263 | $212.11 | +23.99% | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2.75 | $1.16 | +137.07% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $184.99 | +60.55% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.29 | +1,188.66% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $421.12 | -10.95% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $15.27 | +1.51% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $158.86 | +69.96% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $4.48 | +245.98% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $302.89 | +76.96% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $17.99 | +61.20% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $6.36 | +3,799.37% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.82 | - | 5 | Oct 9, 2017 |
UnitedHealth Group
Apr 20, 2026
Maintains: Buy
Price Target: $340 → $373
Current: $393.85
Upside: -5.29%
Elevance Health
Apr 20, 2026
Maintains: Buy
Price Target: $395 → $391
Current: $392.68
Upside: -0.43%
The Cigna Group
Apr 20, 2026
Maintains: Buy
Price Target: $333 → $330
Current: $285.27
Upside: +15.68%
Centene
Apr 20, 2026
Maintains: Hold
Price Target: $37 → $39
Current: $58.27
Upside: -33.07%
Oscar Health
Apr 20, 2026
Upgrades: Hold
Price Target: $10 → $16
Current: $23.32
Upside: -31.39%
ICON Public Limited Company
Feb 23, 2026
Upgrades: Buy
Price Target: $175 → $135
Current: $116.38
Upside: +16.00%
Medpace Holdings
Feb 13, 2026
Upgrades: Buy
Price Target: $560
Current: $415.27
Upside: +34.85%
Humana
Feb 12, 2026
Maintains: Buy
Price Target: $310 → $235
Current: $305.12
Upside: -22.98%
IQVIA Holdings
Feb 6, 2026
Maintains: Buy
Price Target: $270 → $255
Current: $169.12
Upside: +50.78%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $81.69
Upside: -
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $13.66
Upside: -30.45%
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $150.85
Upside: +29.27%
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $212.11
Upside: +23.99%
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.16
Upside: +137.07%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $184.99
Upside: +60.55%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.29
Upside: +1,188.66%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $421.12
Upside: -10.95%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $15.27
Upside: +1.51%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $158.86
Upside: +69.96%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $4.48
Upside: +245.98%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $302.89
Upside: +76.96%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $17.99
Upside: +61.20%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $6.36
Upside: +3,799.37%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.82
Upside: -